Starsource Multitrade Limited (BSE: 506365)
Health Care · Pharmaceuticals · IN
Rs92.80
+3.32% today · -24.7% 1Y
Starsource Multitrade Limited (BSE: 506365) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.45M.
Over the last twelve months the share price has lost 24.7%, trading between 72.00 and 152.90.
Tweenvest scores Starsource Multitrade Limited across four factors: quality 40/100, value 64/100. Its strongest factor is value.
506365 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.45M
- Revenue (TTM)
- $63.82K
- P/E
- —
- EPS
- -0.19
- Dividend yield
- —
- Beta (5Y)
- -0.46
- 52-week high
- Rs152.90
- 52-week low
- Rs72.00
- Avg volume (3M)
- —
- Shares outstanding
- 1.50M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,257.35 | +0.16% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.37 | +0.42% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.90 | -1.25% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.48 | -0.76% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.15 | +0.29% |
Figures last refreshed Aug 18, 2026.